Adaptimmune Therapeutics-ADRADAPY

13F holders, Q3 2025 (September 30)
55holders −10
14new positions
24sold out
1famous investor
$0.13avg. 13F price*

At the end of Q3 2025, 55 institutions reported holding Adaptimmune Therapeutics-ADR (ADAPY) in their 13F filings, down 10 from Q2 2025. 14 opened new positions and 24 sold out. The largest holders were Long Focus Capital Management, LLC ($2.4M), UBS Group AG ($867K) and Renaissance Technologies ($527K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Adaptimmune Therapeutics-ADR
CUSIP
00653A107
Latest filing quarter
Q1 2026

History

Number of 13F holders

020406080100 Q1 2024: 80Q1 2024Q2 2024: 76Q2 2024Q3 2024: 81Q3 2024Q4 2024: 80Q4 2024Q1 2025: 67Q1 2025Q2 2025: 65Q2 2025Q3 2025: 55Q3 2025Q4 2025: 10Q4 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions14$479K
Exits24$19.1M

All 13F filers, Q2 2025 → Q3 2025: 12,961,834 shares bought and 86,452,386 shares sold, net −73,490,552 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 55 holders

Long Focus Capital Management, LLC 0.14% Reduce -21.8% 18,577,821 $2.4M
UBS Group AG 0.00% Add +10490.2% 6,667,358 $867K
Renaissance Technologies 0.00% Add +115.3% 4,054,089 $527K
Morgan Stanley 0.00% Reduce -13.4% 3,666,061 $477K
Jane Street Group, LLC 0.00% New 2,805,345 $365K
Acadian Asset Management LLC 0.00% Reduce -24.4% 1,485,153 $186K
Bank of America Corp. 0.00% Add +15.6% 1,319,669 $172K
Empirical Finance, LLC 0.01% No change 800,000 $104K
B. Riley Wealth Advisors, Inc. 0.00% New 500,000 $65K
Rathbones Group PLC 0.00% No change 432,818 $56K
FMR LLC 0.00% Reduce -26.7% 340,409 $44K
Susquehanna International Group, LLP 0.00% Add +637.3% 308,065 $40K
Lumbard & Kellner, LLC 0.01% New 114,264 $15K
Lakeridge Wealth Management LLC 0.01% New 110,400 $14K
XTX Topco Ltd 0.00% Add +28.1% 102,501 $13K
State of Tennessee, Department of Treasury 0.00% No change 73,376 $10K
Captrust Financial Advisors 0.00% Reduce -13.1% 68,723 $9K
Geode Capital Management, LLC 0.00% No change 67,032 $9K
Group One Trading LLC 0.00% New 61,730 $8K
Sei Investments Co. 0.00% No change 54,824 $7K
State of New Jersey Common Pension Fund D 0.00% No change 54,718 $7K
Federation des caisses Desjardins du Quebec 0.00% No change 53,186 $7K
Northern Trust Corp. 0.00% Reduce -5.4% 48,584 $6K
Wealth Enhancement Advisory Services, LLC 0.00% Add +277.4% 40,816 $6K
BlackRock, Inc. 0.00% Reduce -78.6% 38,296 $5K
Columbia Advisory Partners LLC 0.00% No change 36,730 $5K
SG Americas Securities, LLC 0.00% New 27,497 $4K
Simon Quick Advisors, LLC 0.00% No change 30,000 $4K
Raymond James Financial Inc. 0.00% No change 25,261 $3K
Prosperity Wealth Management, Inc. 0.00% Reduce -2.7% 19,227 $3K
StoneX Group Inc. 0.00% New 15,040 $2K
Traynor Capital Management, Inc. 0.00% New 15,000 $2K
Goldman Sachs Group Inc. 0.00% New 12,320 $2K
Rockefeller Capital Management L.P. 0.00% New 12,166 $2K
IFG Advisory, LLC 0.00% No change 11,725 $2K
Kornitzer Capital Management Inc. 0.00% No change 10,000 $1K
X-Square Capital, LLC 0.00% Add +3.6% 11,573 $1K
Simplex Trading, LLC 0.00% New 12,424 $1K
Rhumbline Advisers 0.00% Reduce -32.7% 5,743 $745
Wells Fargo & Company 0.00% Reduce -94.5% 2,700 $351
Citigroup Inc. 0.00% New 2,679 $348
Barclays PLC 0.00% No change 2,534 $330
Osaic Holdings, Inc. 0.00% Reduce -97.7% 2,058 $198
Tower Research Capital LLC (TRC) 0.00% Reduce -93.6% 700 $91
Wilmington Savings Fund Society, FSB 0.00% No change 604 $79
HighMark Wealth Management LLC 0.00% No change 287 $37
Parallel Advisors, LLC 0.00% No change 250 $33
BNP Paribas Financial Markets 0.00% No change 213 $28
Advisory Services Network, LLC 0.00% New 125 $16
EverSource Wealth Advisors, LLC 0.00% New 100 $13
Investors Research Corp 0.00% No change 100 $13
Koesten, Hirschmann & Crabtree, INC. 0.00% No change 47 $7
TD Waterhouse Canada Inc. 0.00% No change 14 $2
SBI Securities Co., Ltd. 0.00% No change 10 $1
Danske Bank A/S 0.00% No change 1 $0

"% of holder's portfolio" is ADAPY's weight in each manager's 13F, not the share of Adaptimmune Therapeutics-ADR the manager owns.